Therapeutics
LAB0058: Exogenous Surfactant Protein B Mimic
LAB0001: Methods for Treating Refractory Infections in Neutropenic Individuals
LAB0072: Modulation of Myofiber Repair by Anti-Myostatin Strategies and/or PPAR Gamma Ligands, Alone or in Combination with Stem Cells, for the Therapy of Critical Limb Ischemia and Other Ischemic Processes Affecting the Skeletal Muscle
LAB0003: Peptides and Methods for Inducing Cell Death
LAB0007: Compositions and Methods for the Treatment of Mucormycosis and Other Fungal Diseases
LAB0008: Vaccine Compositions and Methods for Treatment of Mucormycosis and Other Fungal Diseases
LAB0009: Antimicrobial Kinocidin Compositions and Methods of Use
LAB0011: Antimicrobial Peptides and Derived Metapeptides
LAB0061: A Method for Modifying Myostatin Expression
LAB0016: Immunotherapy and Diagnosis of Mucormycosis Using CotH
LAB0039: Targeting Pulmonary Epithelium Using ADRP
LAB0014: Multifunctional Context-Activated Protides and Methods of Use
LAB0129: Intensification of Collagen Breakdown in Tissue Fibrosis by a Combination of Metalloproteinases or Collagenases and AGE Cross-link Breakers
LAB0164: Structurally Novel Phenytoin Derivatives with Enhanced Binding to Neuronal Voltage Gated Sodium Channels
LAB0163: Aerosol Delivery of a PPARγ Agonist in Synthetic Lung Surfactant to Prevent Neonatal Lung Injury
LAB0135: Manipulation of Endothelial Yap-Hippo Signaling to Modulate Pulmonary Angiogenesis and Lung Growth and Development
LAB0064: Respiratory Distress Syndrome Therapy with Peptide Analogs of Human SP-B
LAB0094: Induction of Antigen Specific Immunologic Tolerance
LAB0132: Novel SP-B & SP-C Peptides, Synthetic Lung Surfactants, and Use Thereof
LAB0155: Recombinant Human N-acetylglucosamine-6-sulfatase for Sanfilippo D Syndrome
LAB0158: Discovery of Novel Mucormycosis Pathogenesis Mechanism Mediated by Ricin-like Toxin with a Promising Diagnostic and Immunotherapeutic Strategies
LAB0160: Antiparasitic and Antimicrobial Agents
LAB0165: Aerosolized Synthetic Lung Surfactant
LAB0010: Mammalian Receptors as Targets for Antibody and Active Vaccination Therapy Against Mold Infections
LAB0018: Compositions and Methods for Immunization Against Bacteria Expressing A Carbapenemase
LAB0019: Methods and Compositions for Treatment of Multidrug-resistant Bacterial and Fungal Infections
LAB0044: Vaccination with Killed but Metabolically Active (KBMA) Protozoans with Toll-like Receptor Agonists
LAB0144: Prevention and Treatment of Invasive Aspergillosis
LAB0013: Anti-Infective Hydroxyphenyl Benzoates and Methods of Use
LAB0033: Humanin, Analogs and Cancer Treatment Methods and Uses Thereof
LAB0034: Compositions and Methods for Reducing Germ Cell Apoptosis
LAB0043: Treatment for Nicotine-Induced Lung Disease Using Peroxisome Proliferator-Activated Receptor Gamma Agonists
LAB0052: Treatment of Peritoneal Injury Using JAK Inhibitors
LAB0055: Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie’s Disease, Arteriosclerosis, and Other Fibrotic Diseases
LAB0060: Composition and Method for Cancer Chemoprevention
LAB0099: Compositions, Methods and Uses for Protecting White Blood Cells from Suppression or Death
LAB0161: Humanin Compositions, Methods and Uses for Protecting Heart from Stress and Chemotherapy
LAB0162: Proteaosome Activation for Cornea Blindness Treatment
Biomarker
LAB0050: Use of Periostin As a Novel Biomarker
LAB0047: Use of Hematopoietic Growth Factor Inducible Neurokinin-I (HGFIN) as a Biomarker for Renal Injury or Renal Disease
Diagnostic/Prognostic
LAB0027: Method of Inhibiting Lipofibroblast To Myofibroblast Transdifferentiation
LAB0029: Prognostic Assays for Maintenance Hemodialysis Patients
LAB0040: Use of Parathyroid Hormone-related Protein (PTHrP) In the Diagnosis and Treatment of Chronic Lung Disease and Other Pathologies
Medical Devices
LAB0157: Multi-Branched In-Line Thoracic-Abdominal Endoluminal Graft and In-Line Fabrication Mandrel
LAB0140: An Integrated Fiber Optic Sensor Umbilical (ISUM) Catheter for Blood Gas Monitoring in Neonates
LAB0037: Device and Method for Screening Congenital Heart Disease
LAB0063: ECG Lead System for Newborn ECG Screening
LAB0031: Apparatus, Systems and Methods for Detecting Congenital Heart Disease in Newborns
LAB0035: Systems, Apparatus and Methods for Documenting Code Blue Scenarios
LAB0038: Foot Pulse Oximeter for Screening Congenital Heart Disease Before Newborn Discharge
LAB0070: SIDS Monitor
LAB0090: Conjunctival Monitor
LAB0108: Wearable Device for Diagnosis and Assessment of Asthma
LAB0156: Integrated Compact 12-Lead ECG System to Minimize Errors and Enable Home Use
LAB0071: Device to Secure Airway During Emergency Care
LAB0073: Device to Ensure Successful Endotrachael Intubation
LAB0075: Surfactant Administration and Airway for Premature Infants
LAB0109: Valve-assisted Limited Ventilation (Valve) Device
Software/Algorithm
LAB0056: Method and System for Measuring Amniotic Fluid Volume and/or Assessing Fetal Weight
LAB0057: Exercise Test Speed and Grade Modification
LAB0059: Method and System for Detection of Respiratory Variation in Plethysmographic Oximetry
LAB0066: Method and System for Automated Measurement of Pulsus Paradoxus
LAB0067: Method for Thoracic Vertebral Bone Density Measurement by Thoracic Quantitative Computed Tomography
LAB0068: Use of Relatively Permanent Pigmented or Vascular Skin Mark Patterns in Images for Personal Identification
LAB0143: Method and an Apparatus for Determining Vein Patterns from a Color Image
Research Tool
LAB0065: A Stable Isotope Labeling Method for Determination of Protein Synthesis and Protein Expression in the Study of Biological Effects of Drugs and Other Biological Agents